Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Proscia and Datavant partner to connect pathology data with health data ecosystem for life sciences R&D

By Heather Hall | January 13, 2022

Proscia, the digital and computational pathology solutions provider, and Datavant, which securely connects organizations with health data, have announced a partnership that will provide life sciences companies with digitized pathology data to power the development of novel therapeutics and diagnostics. The partnership brings together Datavant’s privacy-preserving connectivity technology and the largest U.S. health data ecosystem with Proscia’s Concentriq digital pathology platform.

Pathology is undergoing a transformation to an image-based, data-driven paradigm across life sciences and diagnostics as labs shift from 150-year-old analog microscope-based practices. According to the CDC, 70% of medical decisions are based on laboratory data, much of which has remained siloed and disconnected from the flourishing healthcare data landscape. Pathology’s digital transformation, which has been accelerated by the COVID-19 pandemic and technology tailwinds, represents the emergence of one of the largest and richest new data mediums in healthcare. Proscia’s proprietary platform is powering diagnostic labs and life science organizations today, including 10 of the top 20 biopharma companies.

Datavant technology and Proscia’s platform, with its extensive library of pathology data, will help life sciences organizations link digital images, curated cancer datasets, and structured insights with other healthcare data in a privacy-preserving way to power next-generation R&D. This compliant linkage, will support the development of novel biomarkers, accelerate clinical trials, and enable real-world evidence in pharma.

“We’ve seen a wellspring of demand for structured pathology data, married with computational technologies, to power precision medicine R&D,” said David West, CEO of Proscia. “Our partnership with Datavant does two things: First, it brings new tools for protecting patient privacy, data security and HIPAA compliance to our Concentriq base. Second, it helps link pathology data with partners in the Datavant ecosystem. Together, this will enable pharma and biotech companies to leverage this new digital medium, cultivating the advancement of new therapies and diagnostics. Ultimately, this data partnership represents the third prong of Proscia’s mission to accelerate medical breakthroughs with our platform, AI and data.”

“Pathology data is one of the most difficult sources of data to transform into usable information,” said Travis May, co-founder and president of Datavant. “Enabling compliant connectivity of digital pathology data to other research data bridges bench science and outcomes research, scaling and accelerating the development of highly tailored precision therapeutics for patients.”

For more information, visit proscia.com.

 

Related Articles Read More >

professional photo of wooly mammoth in nature --ar 2:1 --personalize sq85hce --v 6.1 Job ID: 47185eaa-b213-4624-8bee-44f9e882feaa
Why science ethicists are sounding skepticism and alarm on ‘de-extinction’
ALAFIA system speeds complex molecular simulations for University of Miami drug research
3d rendered illustration of the anatomy of a cancer cell
Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off
Health-related innovation in Morocco highlighted by resident inventor patenting activity
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE